Thursday's session: top gainers and losers
By Mill Chart
Last update: Sep 22, 2022
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Top gainers
| Ticker | Change | Comment |
|---|---|---|
| SPRO | 205.0% | SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 205.0% to a price of $2.5. In the last 6 months the stock lost 89.92%. |
| BOA.W | 100.0% | BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price is advancing with 100.0% to a price of $0.14. The stock is trading 65.5% lower than 3 months ago. |
| AVCTW | 39.86% | PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares rose 39.86% to $0.06. Shareholders saw the stock price going 30.59% higher in the past 3 months. |
| AVCT | 39.03% | AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price increased by 39.03% to $0.3. Shareholders saw the stock price going 53.27% higher in the past month. |
| BEAT | 31.73% | HEARTBEAM INC's (NASDAQ:BEAT) shares rose 31.73% to $2.08. In the last month the share price increased with 20.61%. |
| SONN | 22.73% | SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price is advancing with 22.73% to a price of $1.62. In the last month the stock lost 60.53%. |
| TALK | 19.99% | TALKSPACE INC (NASDAQ:TALK) rose 19.99% to $1.0 during Thursday's after hours session. In the last month the share price dropped with 46.92%. |
| SAVA | 19.85% | CASSAVA SCIENCES INC's (NASDAQ:SAVA) shares rose 19.85% to $45.11 during Thursday's session. In the last month the share price increased with 48.72%. |
| USEA | 19.74% | UNITED MARITIME CORP's (NASDAQ:USEA) stock price increased by 19.74% to $1.82. |
| PIXY | 18.65% | SHIFTPIXY INC's (NASDAQ:PIXY) stock price increased by 18.65% to $16.21. In the last month the share price dropped with 41.32%. |
For the full top gainers list go to our top gainers screener.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| OPP- | -38.46% | River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) stock price is declining with 38.46% to a price of $0.0. In the last month the stock lost 97.61%. |
| BCAN | -26.3% | BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 26.3% to $3.25. |
| MOHO | -25.88% | ECMOHO LTD's (NASDAQ:MOHO) shares fell 25.88% to $0.13 during Thursday's session. The stock is trading 31.61% lower than 6 months ago. |
| TOPS | -25.19% | TOP SHIPS INC's (NASDAQ:TOPS) shares fell 25.19% to $0.16 during Thursday's session. In the last month the stock lost 29.7%. |
| CPTN | -22.92% | CEPTON INC's (NASDAQ:CPTN) shares fell 22.92% to $1.61 during Thursday's session. Yesterday the company had a press release: Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology. |
| SOBR | -20.92% | SOBR SAFE INC's (NASDAQ:SOBR) shares fell 20.92% to $1.89. In the last month the stock gained 115.0%. |
| LAZR | -20.4% | LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 20.4% to $7.46. The stock is trading 25.1% higher than 3 months ago. |
| AGRI | -19.74% | AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) stock price is declining with 19.74% to a price of $1.42. Shareholders saw the stock price going 29.2% lower in the past 3 months. |
| SLNG | -16.07% | STABILIS SOLUTIONS INC's (NASDAQ:SLNG) stock price decreased by 16.07% to $7.42. In the last month the share price increased with 89.7%. |
| IMTE | -16.03% | INTEGRATED MEDIA TECHNOLOGY's (NASDAQ:IMTE) shares fell 16.03% to $0.61 during Thursday's session. The stock is trading 47.03% lower than a month ago. |
To see the full list of top losers you can use our top losers screener.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/23/2024, 12:52:49 PM)
1.46
+0.06 (+4.29%)
SPRO News
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...
6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
